PRMT1 regulates EGFR and Wnt signaling pathways and is a promising target for combinatorial treatment of breast cancerSamyuktha Suresh(Translational Research Institute), Thierry Dubois(Translational Research Institute)bioRxiv (Cold Spring Harbor Laboratory)October 23, 202110.1101/2021.10.22.465320Cited by 1SaveCiteExport RISWatch citationsRelated PapersFrequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells|Breast Cancer Research|2008|211TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer|PLoS ONE|2013|168Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells|PLoS ONE|2015|89PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer|Cancers|2022|35LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers|Oncotarget|2018|33